432 related articles for article (PubMed ID: 31439176)
1. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
[TBL] [Abstract][Full Text] [Related]
4. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
Bhatt G; Vyas S; Trivedil K
Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
Goyal V; Kadam V; Narang P; Singh V
BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
[TBL] [Abstract][Full Text] [Related]
7. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
8. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
Singla N; Singla R; Jain G; Habib L; Behera D
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
[TBL] [Abstract][Full Text] [Related]
11. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
[TBL] [Abstract][Full Text] [Related]
12. Pattern and trends of drug sensitivity in MDR-TB cases in Delhi (2009-2014): A record based study.
Sharma N; Singla N; Khanna A; Basu S; Chopra KK; Chandra S; Kohli C
Indian J Tuberc; 2019 Apr; 66(2):222-226. PubMed ID: 31151488
[TBL] [Abstract][Full Text] [Related]
13. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
[TBL] [Abstract][Full Text] [Related]
14. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.
Sidharta SD; Yin JD; Yoong JS; Khan MS
BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
17. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
Sagar T; Singh NP; Kashyap B; Kaur IR
J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
[TBL] [Abstract][Full Text] [Related]
18. A study on procedural delay in diagnosis and start of treatment in drug resistant tuberculosis under RNTCP.
Sharma AK; Gupta N; Verma S; Chandran A; Dixit R
Indian J Tuberc; 2019 Jul; 66(3):394-401. PubMed ID: 31439186
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India.
Datta BS; Hassan G; Kadri SM; Qureshi W; Kamili MA; Singh H; Manzoor A; Wani MA; Shamas-u-Din ; Thakur N
J Infect Dev Ctries; 2009 Nov; 4(1):19-23. PubMed ID: 20130374
[TBL] [Abstract][Full Text] [Related]
20. Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study.
Sharma N; Khanna A; Chandra S; Basu S; Chopra KK; Singla N; Babbar N; Kohli C
Indian J Med Res; 2020 Jun; 151(6):598-603. PubMed ID: 32719234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
